InVivoMAb Anti-Mouse CD279/PDC
D1/PD1 Antibody (RMP1-14)-(D265A), InVivoMAb 抗小鼠CD279/PDCD1/PD1抗体 (RMP1-14)-(D265A)- ￥1668
- abinScience
- China
- MS870060
- 2026年03月03日
- Neutralization
- Mouse
- Mouse
企业认证
相关产品推荐更多 >
Anti-MACROH2A1 Polyclonal Antibody, 抗MACROH2A1多克隆抗体
￥1008Anti-Human EPHA3 Antibody (SAA0126), FITC, 抗人EPHA3抗体 (SAA0126), FITC标记
询价
Human IgG1, lambda Isotype Control antibody (HyHEL-10), FITC, 同型对照抗体
询价Anti-Human IL4 receptor complex Antibody (A2), APC, 抗人IL4 receptor complex抗体 (A2), APC标记
询价Anti-Human CREB3L2 Polyclonal Antibody, 抗人CREB3L2多克隆抗体
￥1008
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Mouse
- 亚型：
IgG1, kappa (D265A)
- 形态：
Liquid
- 保存条件：
0.01M PBS, pH 7.4.
- 克隆性：
Monoclonal
- 标记物：
Unconjugated
- 适应物种：
Mouse
- 保质期：
1 year
- 抗原来源：
Mouse
- 目录编号：
MS870060
- 级别：
科研级别
- 库存：
999
- 供应商：
abinScience
- 宿主：
Mouse
- 应用范围：
Neutralization
- 浓度：
1mg/mL
- 靶点：
Programmed cell death protein 1, Protein PD-1, hPD-1, PD1, PDCD1, CD279
- 抗体英文名：
InVivoMAb Anti-Mouse CD279/PDCD1/PD1 Antibody (RMP1-14) (D265A)
- 抗体名：
InVivoMAb Anti-Mouse CD279/PDCD1/PD1 Antibody (RMP1-14) (D265A)
- 规格：
100ul
| Product name | InVivoMAb Anti-Mouse CD279/PDCD1/PD1 Antibody (RMP1-14) (D265A) |
|---|---|
| Catalog No. | MS870060 |
| Host species | Mouse |
| Species reactivity | Mouse |
| Immunogen | / |
| Form | Liquid |
| Storage buffer | 0.01M PBS, pH 7.4. |
| Purity | >95% as determined by SDS-PAGE. |
| Clonality | Monoclonal |
| Isotype | IgG1, kappa (D265A) |
| Applications | Neutralization |
| Target | Programmed cell death protein 1, Protein PD-1, hPD-1, PD1, PDCD1, CD279 |
| Purification | Protein A/G purified from cell culture supernatant. |
| Endotoxin level | Please contact with the lab for this information. |
| Expression system | / |
| Accession | Q02242 |
| Alternative Names | / |
| Clone ID | RMP1-14 |
| Species | / |
| Product Usage Information | / |
abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.
Technology and Innovation
Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003, abinScience has inherited advanced technologies and high-quality standards. In particular, the XtenCHO™ system developed by ProteoGenix, which has two modes of transient expression and stable expression, has been widely recognized as a core technology to improve the efficiency of protein production, providing a solid foundation for abinScience's product research and development.
Product categories and application fields.
Main products.
10000+ high-activity proteins.
15000+ antibody series products:
Classic monoclonal antibody.
Monoclonal antibody
Internal control antibody, labeled antibody.
High-quality phosphorylation antibodies.
Highly specific nanobodies and small molecule antibodies.
Functional antibodies in vivo.
Low-background flow cytometry antibodies.
DNA/RNA antibodies and PEG antibodies.
1000+ reagent kit series products.
Large-scale packaging customization services: We offer personalized antibody design, protein production, molecular optimization, and experimental development services.
Application field
Infectious disease research: including viruses, superbugs, parasites, etc.
Neuroscience research: Supporting research on neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Immunology research: Covers the research needs of immune activation, inhibition, and allergies and abnormal reactions.
Oncology research: Supporting the development of tumor biology and anti-tumor drugs.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验• PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations., PMID:30888929
• The diverse functions of the PD1 inhibitory pathway., PMID:28990585
• PD-1/PD-L1 immune checkpoint: Potential target for cancer therapy., PMID:30191996
• Immune Checkpoint Blockade in Cancer Therapy., PMID:25605845
• PD-1 expression and clinical PD-1 blockade in B-cell lymphomas., PMID:29118007
• Overcoming T cell exhaustion in infection and cancer., PMID:25797516
• Tumor Mutational Burden and Response Rate to PD-1 Inhibition., PMID:29262275
• PD-L1., PMID:29097600
• PD-1/PD-L1 in disease., PMID:29260623
ELISPOT (Enzyme-linked ImmunoSPOT)
PBMCs activated with PMA/Ionomycin for 24 hrs. Reference Tables Table 1: Mouse ELISPOT Ready-Set-Go! Sets & Antibody Selection Quick Guide Mouse ELISPOT Ready-Set-Go! Sets & Antibody Selection Quick Guide
技术资料暂无技术资料 索取技术资料
